Our State-of-the Art
Chemistries Drive Innovation.

At Flamingo, we understand drug development – and more importantly – we understand RNA therapeutic drug development.  We know that robust and novel backbone chemistry is paramount when developing any RNA therapeutic, especially for difficult to treat cancers, where many modalities have failed to succeed.  Our company was built upon our deep experience and know-how in this space and we are well-positioned to advance candidates against targets considered “undruggable” by RNA chemistries.

Our FLAME™ Shines
the Light on “Dark Matter”

Flamingo also has a unique discovery engine, FLAME (Flamingo LncRNA Antisense Mining Engine), that addresses lncRNAs, a large and untapped class of disease-causing targets within the “dark matter” of the human genome.

Latest News